LIXIL IMPACT BRIEFING: April 3, 2026 Empowering Change: Scaling Impact in a New Era Copyright © LIXIL Corporation. All rights reserved. Today's Speakers Kinya Seto Director, Representative Executive Officer, President, and Chief Executive Officer Erin McCusker Executive Officer, Executive Vice President, Chief Impact Officer, Communications, External Affairs, and Impact Strategy 1 Outside Director, Chairperson of the Board of Directors and Chairperson of Governance Committee Ryusuke Ohori ––––– Outside Dire ...

Financial Data and Key Metrics Changes - Consolidated sales decreased by 2.2% to $80.3 million, with a $700,000 decrease from retail stores and a $1.1 million decrease from external wholesale customers, primarily due to winter weather impacts [14][3] - Gross margin decreased by 80 basis points to 56.2%, driven by lower margins in both retail and wholesale businesses [14][15] - Operating income was $1.2 million, or 1.4% of sales, compared to $2.5 million, or 3% of sales in the prior period [15] - Diluted earnings per share were $0.13, down from $0.21 [15] Business Line Data and Key Metrics Changes - Retail net sales were $52.5 million, a decrease of 1.4%, primarily due to winter weather impacts [17] - Written sales decreased by 0.2%, while gross margin for retail was 51.5%, down 170 basis points due to delayed price increases related to tariffs [17][4] - Wholesale net sales were $53 million, essentially flat year-over-year, with a 0.6% increase in shipments to the retail core network [16] Market Data and Key Metrics Changes - The company experienced a significant decline in retail written sales during a two-week period in January due to severe weather, impacting both retail and wholesale operations [3][48] - The overall traffic was down in the first quarter, but conversions increased by 130%, resulting in a 28% increase in orders [10] Company Strategy and Development Direction - The company is focusing on five key initiatives to grow the business, including generating comparable store growth, opening new retail locations, increasing e-commerce sales, enhancing Bassett Design Centers, and building the interior design channel [6][12] - The company plans to open corporate stores in Cincinnati and Orlando and relocate a store on Long Island, with meticulous research on sales potential before committing to new locations [9] - Investments are being made to enhance the e-commerce platform and integrate an omni-channel experience, targeting younger, higher-income demographics [10] Management's Comments on Operating Environment and Future Outlook - Management noted ongoing challenges in the macro environment, including weak residential housing activity and higher employee costs, which are headwinds for top-line growth [5] - The company is optimistic about improved retail margins in the upcoming quarters due to the implementation of price increases [22] - Management expressed that while there has not been a significant decline in business trends since the start of the conflict in Ukraine, there has also not been an uptick [31] Other Important Information - The company plans to spend between $8 million and $12 million on capital expenditures for 2026, significantly higher than the previous year's $4.5 million [19] - The company remains committed to delivering shareholder returns through dividends and opportunistic share buybacks, with a quarterly dividend of $0.20 approved [19] Q&A Session Summary Question: Impact of delayed price increases on retail margins - Management acknowledged the impact of delayed price increases and indicated that margins should improve in the second quarter [22][23] Question: Potential additional pricing actions due to fuel price spikes - Management confirmed that surcharges related to freight and petroleum derivative products will need to be passed along to customers [25] Question: Trends observed since the start of the conflict in Ukraine - Management reported no significant changes in business trends, maintaining a steady performance [31] Question: Accessibility to materials and potential price increases - Management indicated no noticeable issues with material accessibility and container prices have not spiked [37] Question: Outlook for retail margins and new store openings - Management expects some losses on the retail side until new stores start producing sales, but anticipates better margins moving forward [39][40] Question: Potential for tariff refunds and impact on the tariff landscape - Management stated that there is uncertainty regarding tariff refunds and the impact of recent Supreme Court decisions [41] Question: Weather impact on sales - Management expressed hope that lost sales due to weather would be deferred rather than permanently lost, but noted significant impacts on retail written sales [44][45] Question: E-commerce sales representation and future reporting - Management indicated that while e-commerce sales are growing, they have not broken out these figures separately in the past [49]

R&D Day 2026 April 2, 2026 Bettering the Lives of People Impacted by Kidney Disease NASDAQ: AKBA 1 Cautionary note on forward-looking statements Statements in this presentation regarding Akebia Therapeutics, Inc.'s ("Akebia's") strategy, plans, prospects, expectations, beliefs, intentions and goals are forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, as amended, and include, but are not limited to, statements regarding: Akebia's plans, strategies an ...

Financial Data and Key Metrics Changes - Consolidated sales decreased by 2.2% to $83 million, a decline of $1.8 million compared to the previous year [14] - Gross margin decreased by 80 basis points to 56.2%, primarily due to lower margins in both retail and wholesale businesses [14] - Operating income was $1.2 million, or 1.4% of sales, down from $2.5 million, or 3% of sales in the prior period [15] - Diluted earnings per share were $0.13, compared to $0.21 in the previous year [15] Business Line Data and Key Metrics Changes - Retail net sales were $52.5 million, a decrease of $800,000 or 1.4%, primarily due to winter weather impacts [17] - Wholesale net sales were $53 million, essentially flat compared to last year, with a 0.6% increase in shipments to the retail core network [16] - Written sales were flat for the first quarter, but there was a double-digit increase in written orders for the back half of February [4] Market Data and Key Metrics Changes - The company experienced significant disruptions in retail and wholesale sales due to severe weather, with over 50% of retail locations closed during critical weekends [4] - The macro environment remains challenging with weak residential housing activity and higher employee costs impacting sales [5] Company Strategy and Development Direction - The company is focusing on five key initiatives to drive growth: generating comparable store growth, opening additional retail locations, increasing e-commerce sales, enhancing Bassett Design Centers, and building the interior design channel [13] - The company plans to open corporate stores in Cincinnati and Orlando and relocate a store on Long Island [9] - Investments are being made to improve e-commerce capabilities and integrate an omni-channel experience [10] Management's Comments on Operating Environment and Future Outlook - Management noted that the pace of business slowed abruptly in mid-January, impacting sales and margins [3] - There is cautious optimism regarding improved retail margins due to recent price adjustments [22] - The company is addressing higher SG&A expenses and is implementing initiatives projected to save between $1.5 million and $2 million annually [5] Other Important Information - The company maintains a solid liquidity position with $51 million in cash and short-term investments [18] - Total capital expenditures for 2026 are expected to be between $8 million and $12 million, significantly higher than the previous year's $4.5 million [19] - The company continues to pay dividends and repurchase shares opportunistically, with a $0.20 dividend approved for payment on May 29 [19] Q&A Session Summary Question: Impact of delayed price increases on retail margins - Management acknowledged the impact of delayed price increases and indicated that margins should improve in the second quarter [22][23] Question: Potential additional pricing actions due to fuel price spikes - Management confirmed that surcharges related to fuel prices are already being implemented and will need to be passed along to customers [24][25] Question: Trends observed since the start of the conflict in Ukraine - Management reported no significant changes in trends, with sales remaining stable but not showing an uptick [32] Question: Accessibility to materials and potential price increases - Management indicated no noticeable issues with accessibility to materials and did not foresee immediate price increases due to geopolitical tensions [38] Question: Outlook for retail margins and new store openings - Management expects some losses in retail margins until new stores begin generating sales, but anticipates better margins moving forward [40][41] Question: Potential for tariff refunds and impact of Supreme Court decision - Management stated that there is uncertainty regarding tariff refunds and the impact of recent legal decisions [42] Question: Weather impact on sales - Management expressed hope that lost sales due to weather would be deferred rather than permanently lost, but acknowledged the significant impact on sales [45][46] Question: E-commerce sales representation and future reporting - Management noted that while e-commerce sales are growing, they have not broken out these figures separately in the past [50]

Financial Data and Key Metrics Changes - In Q4 2025, revenue was $33.4 million, down approximately 15% year-over-year, with same-store revenue declining 16% [14] - For the full year 2025, total revenue was $151.8 million, a decrease of approximately 15.8% compared to fiscal 2024 [15] - Adjusted EBITDA for Q4 was $2.5 million, representing a margin of 7.4%, an increase of $0.6 million and 2.8% margin expansion year-over-year [15] - Full year adjusted EBITDA was approximately $15 million, resulting in an adjusted EBITDA margin of approximately 10% [15] Business Line Data and Key Metrics Changes - The company reported improvements in lead and consult volumes, which have continued into 2026, contributing to improved revenue trends [5] - Over 100 skin removal surgeries were completed in Q4 2025, with expectations for ramp-up in 2026 as capabilities expand across all locations [8] Market Data and Key Metrics Changes - The skin tightening and skin removal market is projected to be as large as fat removal, representing a long-term sales opportunity exceeding $100 million [7] - The percentage of patients using financing for procedures was approximately 50% [14] Company Strategy and Development Direction - The company is focused on introducing new services to capture the GLP-1 market opportunity, enhancing sales and marketing strategies, and maintaining strong financial discipline [6] - Strategic exit from the only clinic outside North America was made to streamline operations [5] - The company aims to build on momentum and drive disciplined growth to create shareholder value [10] Management's Comments on Operating Environment and Future Outlook - Management noted that 2025 was a year of rebuilding and transformation, with same-store sales improving from down 22% at the start of 2025 to positive in February 2026 [5] - The company expects revenue in 2026 to range from $151 million to $157 million, reflecting approximately 3% comparable growth [17] - Management expressed confidence in the full-year outlook, citing improved trends and a focus on execution [22] Other Important Information - The company paid down $19 million of debt in 2025, with gross debt outstanding at $56 million at year-end [16] - A reconciliation matter related to intercompany transactions was identified, leading to immaterial changes in prior year balances, but had no impact on revenue or cash [13] Q&A Session Summary Question: Guidance for 1Q indicates a slight decline year-over-year, while full year 2026 revenue is expected to be up slightly. What is causing this change in seasonality? - Management acknowledged improved trends and emphasized the need for consistent results to meet guidance [22] Question: Can you provide insights on body sculpting trends outside of GLP-1 related procedures? - Management noted that the core business around body contouring and fat removal is holding steady, with GLP-1s expected to drive future demand [23] Question: What feedback have you received from customers and surgeons regarding excisional procedures? - Management reported positive early results from patients and comfort among surgeons, with plans to ramp up procedures throughout the year [27] Question: How should capital allocation be viewed going forward regarding debt pay down versus investments? - Management indicated that the priority remains on maintaining a healthy balance sheet while also investing back into the business for growth initiatives [29]

Financial Data and Key Metrics Changes - In Q4 2025, revenue was $33.4 million, down approximately 15% year-over-year, with same-store revenue declining 16% [14] - For the full year 2025, total revenue was $151.8 million, a decrease of approximately 15.8% compared to fiscal 2024 [15] - Adjusted EBITDA for Q4 was $2.5 million, representing a margin of 7.4%, an increase of $0.6 million and 2.8% margin expansion year-over-year [15] - Full year adjusted EBITDA was approximately $15 million, resulting in an adjusted EBITDA margin of approximately 10% [15] Business Line Data and Key Metrics Changes - The company reported improvements in lead and consult volumes, contributing to better revenue trends moving into 2026 [5] - Over 100 skin removal surgeries were completed in Q4 2025, with expectations for ramp-up in 2026 as capabilities expand across all locations [8] Market Data and Key Metrics Changes - The skin tightening and skin removal market is projected to be as large as fat removal, representing a long-term sales opportunity exceeding $100 million [7] - The percentage of patients using financing for procedures was approximately 50% [14] Company Strategy and Development Direction - The company is focusing on introducing new services to capture the GLP-1 market opportunity, enhancing sales and marketing strategies, and maintaining strong financial discipline [6] - Strategic exit from the only clinic outside North America was made to streamline operations [5] - The company aims to build on momentum and drive disciplined growth to create shareholder value [10] Management's Comments on Operating Environment and Future Outlook - Management noted that 2025 was a year of rebuilding and transformation, with same-store sales improving from down 22% at the start of 2025 to positive in February 2026 [5] - The company expects revenue in 2026 to range from $151 million to $157 million, reflecting approximately 3% comparable growth [17] - Management acknowledged the need to monitor the helium plasma supply situation due to geopolitical issues affecting skin tightening procedures [18] Other Important Information - The company paid down $19 million of debt in 2025, with gross debt outstanding at $56 million at year-end [16] - Cash flow from operations for the year was $3.1 million, down from $11.4 million in fiscal 2024 [17] Q&A Session Summary Question: Guidance for 1Q indicates a slight decline year-over-year, while full year 2026 revenue is expected to be up slightly. What is causing this change in seasonality? - Management indicated that trends have improved significantly, and they are focused on execution to ensure they meet their numbers [22] Question: Can the company isolate market trends for the core business outside of GLP-1 related procedures? - Management noted that the core business around body contouring and fat removal is holding steady, with GLP-1 being the next wave of change [23] Question: What feedback has the company received regarding excisional procedures from the pilot phase? - Management reported excellent results from patients and comfort from surgeons, with plans to ramp up procedures as the year progresses [27] Question: How should capital allocation be viewed going forward regarding debt pay down versus business investment? - Management emphasized the priority of maintaining a healthy balance sheet while also investing back into the business for growth initiatives [29]

Financial Data and Key Metrics Changes - In Q4 2025, revenue was $33.4 million, down approximately 15% year-over-year, with same-store revenue declining 16% [14] - For the full year 2025, total revenue was $151.8 million, a decrease of approximately 15.8% compared to fiscal 2024 [15] - Adjusted EBITDA for Q4 was $2.5 million, representing a margin of 7.4%, an increase of $0.6 million and 2.8% margin expansion year-over-year [15] - Full year adjusted EBITDA was approximately $15 million, resulting in an adjusted EBITDA margin of approximately 10% [15] Business Line Data and Key Metrics Changes - The company reported improvements in same-store sales, which improved from down 22% at the start of 2025 to positive growth in February 2026 [5] - Over 100 skin removal surgeries were completed in Q4 2025, with expectations for ramp-up in 2026 as capabilities expand across all locations [8] Market Data and Key Metrics Changes - The skin tightening and skin removal market is projected to be as large as fat removal, representing a long-term sales opportunity exceeding $100 million [7] - The percentage of patients using financing for procedures was approximately 50% [14] Company Strategy and Development Direction - The company is focusing on introducing new services to capture the GLP-1 market opportunity, enhancing sales and marketing strategies, and maintaining strong financial discipline [6] - Strategic exit from the only clinic outside North America was made to streamline operations [5] - The company aims to build on momentum and drive disciplined growth to create shareholder value [10] Management's Comments on Operating Environment and Future Outlook - Management noted that 2025 was a year of rebuilding and transformation, with a focus on stabilizing the core business and improving operational performance [5] - For 2026, the company expects revenue in the range of $151 million to $157 million, reflecting approximately 3% comparable growth [17] - Management expressed confidence in the full-year outlook, citing improved trends and a focus on execution [21] Other Important Information - The company paid down $19 million of debt in 2025, with gross debt outstanding at $56 million at year-end [16] - A reconciliation matter related to intercompany transactions was identified, leading to immaterial changes in prior year balances, but had no impact on revenue or cash [13] Q&A Session Summary Question: Guidance for 1Q indicates a slight decline year-over-year, while full year 2026 revenue is expected to be up slightly. What is causing this change in seasonality? - Management acknowledged improved trends and emphasized the need for consistent results to meet guidance [21] Question: Can the company isolate market trends for the core business outside of GLP-1 related procedures? - Management noted that the core business around body contouring and fat removal is holding steady, with GLP-1s expected to drive future demand [22] Question: Feedback on excisional procedures pilot and plans for broader rollout? - Management reported excellent results from the pilot, with positive feedback from patients and surgeons, and plans to ramp up procedures throughout the year [25] Question: Thoughts on capital allocation and debt pay down strategy? - Management indicated that the priority remains on maintaining a healthy balance sheet, with plans to refinance debt while investing back into the business [28]

Financial Data and Key Metrics Changes - The company reported net sales of $1.1 billion, which was $49 million or 5% above the prior year, driven by growth in Acuity Intelligent Spaces (AIS) [15] - Adjusted operating profit was $176 million, an increase of $13 million or 8% from last year, with an adjusted operating profit margin of 16.7%, up 50 basis points from the prior year [15] - Adjusted diluted earnings per share increased to $4.14, reflecting an increase of $0.41 or 11% compared to the prior year [16] Business Line Data and Key Metrics Changes - Acuity Brands Lighting (ABL) sales were $817 million, a decrease of $23 million or 3% versus the prior year, primarily due to declines in the direct sales channel [16] - ABL delivered a gross profit margin of 45.7%, an increase of 70 basis points compared to the prior year, driven by strategic pricing and productivity improvements [16] - AIS sales for the second quarter were $248 million, an increase of $77 million, driven by strong growth in Distech and QSC [17] Market Data and Key Metrics Changes - The company expects full-year ABL sales performance to be flat to down low single digits year-over-year, reflecting current market dynamics [12] - The impact of data centers is creating a crowding out effect on labor and project releases, leading to slower project timelines [28] Company Strategy and Development Direction - The company is focused on product vitality, elevating service levels, and using technology to improve operations and drive productivity [5] - The growth algorithm aims to ensure the company outgrows the lighting market by entering new verticals and taking market share [6] - The company is confident in the long-term performance of both the lighting and spaces businesses, with a focus on growth and margin expansion [13] Management's Comments on Operating Environment and Future Outlook - Management noted that the market is seeking consistency around policy and tariffs, which is impacting project timelines [27] - The company is managing gross profit margins through strategic pricing and productivity improvements, positioning itself well for future opportunities [12] - Management expressed confidence in the ability to adapt to changes in the market, including potential tariff impacts [32] Other Important Information - The company generated $230 million of cash flow from operations in the first half of fiscal 2026, which was $38 million higher than the same period in fiscal 2025 [18] - The company repaid $100 million of its term loan during the quarter, bringing the total repaid this year to $200 million [18] - The quarterly dividend was increased by 18% to $0.20 per share, and $106 million was allocated to repurchase shares [19] Q&A Session Summary Question: Demand trends in ABL - Management highlighted that the market is looking for consistency and that project releases are slower than historically observed, with no indication of losing market share [28][29] Question: Impact of tariffs - Management stated that they have a dynamic supply chain and have managed through tariffs effectively, with most products being unaffected by potential new tariffs [32] Question: ABL gross margin drivers - Management attributed the increase in ABL gross margins to productivity improvements and strategic pricing, with confidence in continuing this trend [36][39] Question: Cost pressures and price increases - Management acknowledged some cost pressures due to data centers impacting labor availability but indicated they would manage through it as they have in the past [49][50] Question: AIS revenue outlook - Management confirmed no change to the AIS growth outlook, expecting low- to mid-teens growth for the year [89]

Financial Data and Key Metrics Changes - Cheche Group achieved adjusted net income of RMB 11.6 million or $1.7 million for the full year 2025, a significant improvement from an adjusted net loss of RMB 24.8 million in the prior year, marking a swing of over RMB 35 million [5] - Total written premiums increased by 11% year-over-year to RMB 27 billion or $3.9 billion for the full year 2025 [14] - Net revenues for the full year 2025 were RMB 3.0 billion or $430.4 million, a decrease of 13.3% year-over-year, primarily due to the higher proportion of NEV premiums [16] Business Line Data and Key Metrics Changes - NEV premiums represented 24.1% of total written premiums in the second half of 2025, up from 17.2% in the prior year period, and 23.4% for the full year 2025, up from 13.6% in the prior year [15] - The total number of policies issued grew from 17.3 million to 20.3 million for the full year 2025 [14] Market Data and Key Metrics Changes - Cheche's partnerships with 16 NEV manufacturers generated 1.2 million embedded policies and RMB 3.7 billion in written premiums in the second half of 2025, representing year-over-year growth of 61.8% and 63.9% respectively [15] - Chinese automakers are exporting over 8 million vehicles annually, creating a demand for intelligent data-driven insurance and financial services [12] Company Strategy and Development Direction - The company is transitioning from a transactional insurance platform to an AI-powered intelligent insurance ecosystem, focusing on enhancing operational capabilities through AI [4][10] - Cheche aims to deepen existing partnerships with NEV manufacturers and expand into international markets, leveraging its digital insurance and financial technology capabilities [11][12] Management's Comments on Operating Environment and Future Outlook - Management highlighted the resilience of the business model despite fee rate compression and expressed confidence in the trajectory of the business moving into 2026 [4][13] - The company anticipates a significant increase in NEV premiums for 2026, projecting growth between 66.7% and 90.5% year-over-year [29] Other Important Information - The company reported RMB 160.8 million or $24.4 million in cash equivalents as of December 31, 2025 [22] - Cheche expects adjusted net income to multiply several folds compared to the full year of 2025 [23] Q&A Session Summary Question: What will drive strong adoption of NEV premiums? - Management emphasized the integration of AI across workflows to enhance efficiency and the use of AI tools to extend capabilities across the insurance value chain [30][31] Question: Can you explain your fintech solutions for international expansion? - Management described strategic partnerships with automotive brands to support Chinese automakers in their overseas expansion, leveraging digital insurance capabilities [32][33] Question: How is AI being leveraged to reduce operating costs? - Management acknowledged the internal use of AI to support operations but did not provide specific details in the response [45]

Financial Data and Key Metrics Changes - Revenue increased by 8.9% to $78.4 million, driven by growth in both MedTech and Med Device segments [13] - Adjusted EBITDA improved to $1.8 million from $1.3 million year-over-year, attributed to MedTech revenue growth and operational efficiency [18] - Gross margin for Q3 FY 2026 was 52.9%, a decrease of 110 basis points from the previous year, primarily due to tariffs and inflation [16] Business Line Data and Key Metrics Changes - MedTech revenue reached $37.3 million, a 19% increase, comprising 48% of total revenue compared to 44% a year ago [13] - Auryon platform generated $16.3 million in revenue, growing 17.9% year-over-year, marking 19 consecutive quarters of double-digit growth [13][14] - Mechanical thrombectomy revenue, including AngioVac and AlphaVac, increased by 17.9% to $11.5 million, with AlphaVac revenue growing 47.4% year-over-year [14] Market Data and Key Metrics Changes - The Med Device segment saw a modest increase of 1.1% year-over-year, with a year-to-date growth of 3% [15] - NanoKnife revenue increased by 21% to $7.6 million, driven by strong demand in prostate care and capital sales [15] Company Strategy and Development Direction - The company is focused on driving profitable growth in high-margin MedTech markets, with a strategic shift towards hospital settings [5][41] - Continued investment in R&D is planned, targeting approximately 10% of sales to support long-term growth [17] - The company is raising its full-year guidance for net sales and adjusted EBITDA for the third consecutive quarter, reflecting confidence in its growth strategy [21] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the resilience of the business despite macroeconomic challenges, including tariffs and inflation [5][19] - The company anticipates continued growth in the AlphaVac product line and expects to maintain strong performance in the MedTech segment [30][38] Other Important Information - The company plans to increase inventory levels in anticipation of temporary sterilization shutdowns, which may slightly impact cash flow [23][50] - The leadership transition process is underway, with a search committee formed to find a successor for the current CEO [24] Q&A Session Summary Question: AlphaVac sequential growth drivers and impact of PE guidelines - Management noted that growth is driven by new hospital approvals and physician comfort with the product, expecting continued sequential growth [29][30] Question: Guidance impact from higher energy costs and supplier costs - Management confirmed that guidance accounts for inflationary pressures and tariffs, with some ability to raise prices on superior products [32][33] Question: Future baseline for AlphaVac revenue - Management expects AlphaVac to continue growing sequentially, viewing current revenue as a strong driver for future growth [38] Question: Auryon volume versus price dynamics - Management highlighted the strategic shift towards hospital settings, which supports pricing and volume growth, and expects Auryon to continue growing [40][41] Question: Supply chain exposure to China and sterilization shutdowns - Management indicated minimal risk from China sourcing and noted that sterilization shutdowns are not frequent, with plans in place to mitigate any disruptions [48][50]